Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications
05 Décembre 2024 - 2:30PM
Business Wire
While 8 out of 10 U.S. adults trying to lose
weight are eager to reach their goal as soon as possible, they
agree that weight loss is an ongoing process requiring consistent
attention and effort*
Medifast (NYSE: MED), the health and wellness company known for
its habit-based and coach-guided lifestyle solution
OPTAVIA®, today shared findings from a recent independent
survey. Commissioned by Medifast and conducted by the third-party
market research firm Talker Research, the goal of the survey was to
better understand American perceptions of weight loss medications
and their role in health journeys, while also identifying areas
where further support is necessary.
The survey of 2,000 nationally representative U.S. adults who
are trying to lose weight revealed that while weight loss
medications are seen as a viable tool, there is a clear
understanding among respondents that medications are not a
standalone solution. 65% of respondents believe that weight loss
medications are more effective when used together with lifestyle
changes, and 45% agreed that medications alone won't allow them to
reach their long-term goals.
Moreover, the survey found that even if weight loss medications
were readily available, a majority of respondents would still
commit to lifestyle changes to reach their goals. Specifically, 73%
said they would commit to healthy eating, 72% would commit to
regular exercise, and 55% would prioritize quality sleep.
Other notable findings include:
- More than half (58%) of respondents said they wished they
had more support on their weight loss journeys.
- 58% of respondents said they would be inclined to try a
medically supported weight loss program if it offered
personalized meal plans and a support group.
“Weight loss is a journey that requires a holistic approach,
including proper nutrition, adequate exercise, sufficient sleep,
and a healthy mindset,” said Dan Chard, chairman and chief
executive officer of Medifast. “The survey results clearly point to
a growing need and desire among U.S. adults for a more
comprehensive, balanced approach to weight loss that complements or
goes beyond just medication. It is evident that the majority of
people trying to lose weight understand the importance of lifestyle
changes and are looking for effective tools and support to help
them in their efforts.”
Chard added, "With our habit-based and coach-guided lifestyle
solution, OPTAVIA, Medifast is uniquely positioned to meet
this clear consumer demand. We offer customized programs and the
support of coaches who draw upon their own personal weight loss
experience – two of the top tools respondents identified as
crucial. Our coaches not only help people lose the weight, but also
teach them how to keep it off. For more than 40 years, Medifast has
committed to championing nutrition and lifestyle changes, aligning
perfectly with the needs and wants of those striving to create a
healthy lifestyle. As the market continues to grow, we remain
dedicated to supporting individuals in achieving their health and
wellness goals through a holistic approach that incorporates both
lifestyle changes and, where clinically appropriate, weight loss
medications."
Studies have shown that use of FDA-approved GLP-1 medications
together with a lifestyle modification program like OPTAVIA
may help you achieve an average reduction in body weight of 15%
(Wadden et al., 2021; Wilding et al., 2021). Medifast embraces this
holistic strategy and leverages this data in its unique approach.
The company offers personalized plans that incorporate both the use
of appropriate medications and the support of experienced coaches
who have personally navigated their own weight loss journeys to
create a comprehensive framework for a healthy lifestyle.
*This random double-opt-in survey of 2,000 people who are trying
to lose weight was commissioned by Medifast between May 2, 2024,
and May 8, 2024. It was conducted by market research company Talker
Research, whose team members are members of the Market Research
Society (MRS) and the European Society for Opinion and Marketing
Research (ESOMAR).
About Medifast®:
Medifast (NYSE: MED) is the health and wellness company known
for its habit-based and coach-guided lifestyle solution
OPTAVIA®, which provides people with a simple yet
comprehensive approach to address obesity and support a healthy
lifestyle. OPTAVIA’s holistic solution includes lifestyle
plans with clinically proven health benefits, scientifically
developed products, and a framework for habit creation – all
reinforced by independent coach support for customers on their
weight loss journeys. Through its collaboration with national
virtual primary care provider LifeMD® (Nasdaq: LFMD) and its
affiliated medical group, the holistic solution now includes access
to GLP-1 medications where clinically appropriate. Medifast remains
committed to its mission of offering Lifelong Transformation,
Making a Healthy Lifestyle Second Nature™. Visit the OPTAVIA
and Medifast websites for more information and follow @Medifast on
X and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241204987167/en/
Public Relations: Jessica Oring,
Jessica.Oring@medifastinc.com
Medifast (NYSE:MED)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Medifast (NYSE:MED)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024